Anti-Mouse CD27 In Vivo Antibody - Ultra-Ultra Low Endotoxin (RM27-3E5)

Anti-Mouse CD27 In Vivo Antibody - Ultra-Ultra Low Endotoxin (RM27-3E5)

Catalog Number:
A001437675ICH
Mfr. No.:
ICH1185UL
Price:
$832
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Antigen Distribution: CD27 is expressed on T cells, B cells, and NK cells
          Specificity: RM27-3E5 activity is directed against mouse CD27
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Rat IgG1 Isotype Control for In Vivo – Low Endotoxin (GL113) [ICH2246]
          Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method
          Aggregation: Aggregation level ≤ 1%

          Please contact us at for specific academic pricing.

          Background

          CD27 is a glycosylated, type I transmembrane protein of the TNFR superfamily that is constitutively expressed on the surface of progenitor and naïve T cells as well as subsets of natural killer (NK) and B cells. CD27 is an immune-checkpoint receptor and ligation with CD70 results in co-stimulatory effects that enhance primary, memory, and recall T cell responses. CD27 signaling has been targeted for the development of viral, autoimmune, and anti-tumor immunotherapies.

          RM27-3E5 (rat IgG2a) was raised against recombinant mouse CD27-human IgG1 Fc fusion protein and purified from ascites using protein G columns. RM27-3E5 enhances anti-CD3-stimulated T cell proliferation when immobilized in vitro and augments ovalbumin-specific cytotoxic T lymphocyte (CTL) induction when administered in vivo.

          RM27-3E5 is an agonistic antibody and has been found to support the control of both established lung metastases and subcutaneous tumors. An anti-tumor effect was also observed with RM27-3E5 against EG7/CD27(+) and EG7/CD27(−) tumors, with the effect mediated mainly by T cells with a minor contribution by NK cells. RM27-3E5 exerts its potent anti-tumor effect by inducing a tumor-specific CTL response. RM27-3E5 has potential utility as a non-depleting agonistic anti-CD27 mAb to enhance anti-tumor immunity

      • Properties
        • Host
          rat
          Isotype
          IgG1 kappa
          Reactivity
          mouse
          Clone
          RM27-3E5
          Immunogen
          Mouse CD27-human IgG1 Fc fusion protein
          Purification
          >98% by SDS-PAGE and HPLC
          Formulation
          This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
          Storage
          This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
          Molecular Weight
          ≥ 5.0 mg/ml
          Regulatory Status
          Each investigator should determine their own optimal working dilution for specific applications.
          Antigen

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays; Flow Cytometry; ImmunoPrecipitation

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.